ALBEMARLE CORP (ALB) Fundamental Analysis & Valuation

NYSE:ALB • US0126531013

Current stock price

163.26 USD
-2.57 (-1.55%)
At close:
163.26 USD
0 (0%)
After Hours:

This ALB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALB Profitability Analysis

1.1 Basic Checks

  • ALB had negative earnings in the past year.
  • In the past year ALB had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ALB reported negative net income in multiple years.
  • Each year in the past 5 years ALB had a positive operating cash flow.
ALB Yearly Net Income VS EBIT VS OCF VS FCFALB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -4.14%, ALB is doing worse than 67.47% of the companies in the same industry.
  • The Return On Equity of ALB (-7.11%) is worse than 61.45% of its industry peers.
  • ALB has a Return On Invested Capital of 0.37%. This is in the lower half of the industry: ALB underperforms 73.49% of its industry peers.
Industry RankSector Rank
ROA -4.14%
ROE -7.11%
ROIC 0.37%
ROA(3y)-1.15%
ROA(5y)3.02%
ROE(3y)-1.2%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
ALB Yearly ROA, ROE, ROICALB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • ALB has a worse Operating Margin (1.34%) than 67.47% of its industry peers.
  • ALB's Operating Margin has declined in the last couple of years.
  • The Gross Margin of ALB (13.00%) is worse than 77.11% of its industry peers.
  • In the last couple of years the Gross Margin of ALB has declined.
Industry RankSector Rank
OM 1.34%
PM (TTM) N/A
GM 13%
OM growth 3Y-63.89%
OM growth 5Y-37.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-32.21%
GM growth 5Y-16.29%
ALB Yearly Profit, Operating, Gross MarginsALB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ALB Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALB is destroying value.
  • The number of shares outstanding for ALB remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, ALB has more shares outstanding
  • The debt/assets ratio for ALB has been reduced compared to a year ago.
ALB Yearly Shares OutstandingALB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ALB Yearly Total Debt VS Total AssetsALB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 2.60 indicates that ALB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.60, ALB is in the better half of the industry, outperforming 72.29% of the companies in the same industry.
  • The Debt to FCF ratio of ALB is 4.61, which is a neutral value as it means it would take ALB, 4.61 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 4.61, ALB belongs to the best of the industry, outperforming 81.93% of the companies in the same industry.
  • A Debt/Equity ratio of 0.33 indicates that ALB is not too dependend on debt financing.
  • ALB's Debt to Equity ratio of 0.33 is fine compared to the rest of the industry. ALB outperforms 73.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 4.61
Altman-Z 2.6
ROIC/WACC0.04
WACC8.28%
ALB Yearly LT Debt VS Equity VS FCFALB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 2.23 indicates that ALB has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.23, ALB is doing good in the industry, outperforming 61.45% of the companies in the same industry.
  • ALB has a Quick Ratio of 1.57. This is a normal value and indicates that ALB is financially healthy and should not expect problems in meeting its short term obligations.
  • ALB has a Quick ratio of 1.57. This is in the better half of the industry: ALB outperforms 65.06% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.57
ALB Yearly Current Assets VS Current LiabilitesALB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALB Growth Analysis

3.1 Past

  • ALB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.24%, which is quite impressive.
  • The Revenue has decreased by -4.37% in the past year.
  • ALB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.45% yearly.
EPS 1Y (TTM)66.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.38%
Revenue 1Y (TTM)-4.37%
Revenue growth 3Y-11.1%
Revenue growth 5Y10.45%
Sales Q2Q%15.94%

3.2 Future

  • Based on estimates for the next years, ALB will show a very strong growth in Earnings Per Share. The EPS will grow by 94.11% on average per year.
  • ALB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.41% yearly.
EPS Next Y1051.57%
EPS Next 2Y263.09%
EPS Next 3Y149.67%
EPS Next 5Y94.11%
Revenue Next Year11.12%
Revenue Next 2Y8.63%
Revenue Next 3Y8.48%
Revenue Next 5Y11.41%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALB Yearly Revenue VS EstimatesALB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ALB Yearly EPS VS EstimatesALB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALB Valuation Analysis

4.1 Price/Earnings Ratio

  • ALB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 21.72, which indicates a rather expensive current valuation of ALB.
  • ALB's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.80, ALB is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 21.72
ALB Price Earnings VS Forward Price EarningsALB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALB is valued a bit more expensive than 79.52% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ALB is valued a bit cheaper than 60.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 27.79
EV/EBITDA 29.03
ALB Per share dataALB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ALB's earnings are expected to grow with 149.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y263.09%
EPS Next 3Y149.67%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ALB Dividend Analysis

5.1 Amount

  • ALB has a yearly dividend return of 0.99%, which is pretty low.
  • Compared to an average industry Dividend Yield of 2.08, ALB has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.91, ALB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.99%

5.2 History

  • On average, the dividend of ALB grows each year by 14.86%, which is quite nice.
  • ALB has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ALB has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)14.86%
Div Incr Years30
Div Non Decr Years30
ALB Yearly Dividends per shareALB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • ALB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • ALB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-52.74%
EPS Next 2Y263.09%
EPS Next 3Y149.67%
ALB Yearly Income VS Free CF VS DividendALB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

More info and screens

Find the best dividend stocksShow peers with best dividend

ALB Fundamentals: All Metrics, Ratios and Statistics

ALBEMARLE CORP

NYSE:ALB (3/19/2026, 5:44:43 PM)

After market: 163.26 0 (0%)

163.26

-2.57 (-1.55%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-11
Earnings (Next)04-28
Inst Owners94.66%
Inst Owner Change-0.46%
Ins Owners0.32%
Ins Owner Change-4.34%
Market Cap19.24B
Revenue(TTM)5.14B
Net Income(TTM)-677.38M
Analysts76.67
Price Target190.59 (16.74%)
Short Float %8.46%
Short Ratio3.3
Dividend
Industry RankSector Rank
Dividend Yield 0.99%
Yearly Dividend3.04
Dividend Growth(5Y)14.86%
DP-52.74%
Div Incr Years30
Div Non Decr Years30
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)23.68%
Min EPS beat(2)-28.49%
Max EPS beat(2)75.86%
EPS beat(4)3
Avg EPS beat(4)57.57%
Min EPS beat(4)-28.49%
Max EPS beat(4)113.21%
EPS beat(8)3
Avg EPS beat(8)-20.89%
EPS beat(12)6
Avg EPS beat(12)-0.71%
EPS beat(16)10
Avg EPS beat(16)3.12%
Revenue beat(2)2
Avg Revenue beat(2)3.19%
Min Revenue beat(2)1.46%
Max Revenue beat(2)4.93%
Revenue beat(4)3
Avg Revenue beat(4)1.72%
Min Revenue beat(4)-7.88%
Max Revenue beat(4)8.39%
Revenue beat(8)5
Avg Revenue beat(8)0.57%
Revenue beat(12)6
Avg Revenue beat(12)-0.61%
Revenue beat(16)7
Avg Revenue beat(16)-0.65%
PT rev (1m)11.28%
PT rev (3m)74.53%
EPS NQ rev (1m)4731.67%
EPS NQ rev (3m)341.03%
EPS NY rev (1m)173.91%
EPS NY rev (3m)4396.44%
Revenue NQ rev (1m)6.17%
Revenue NQ rev (3m)17.85%
Revenue NY rev (1m)0.53%
Revenue NY rev (3m)9.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.72
P/S 3.74
P/FCF 27.79
P/OCF 15
P/B 2.02
P/tB 2.46
EV/EBITDA 29.03
EPS(TTM)-0.79
EYN/A
EPS(NY)7.52
Fwd EY4.6%
FCF(TTM)5.88
FCFY3.6%
OCF(TTM)10.88
OCFY6.66%
SpS43.64
BVpS80.89
TBVpS66.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.14%
ROE -7.11%
ROCE 0.47%
ROIC 0.37%
ROICexc 0.42%
ROICexgc 0.48%
OM 1.34%
PM (TTM) N/A
GM 13%
FCFM 13.46%
ROA(3y)-1.15%
ROA(5y)3.02%
ROE(3y)-1.2%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-69.86%
ROICexgc growth 5Y-39.71%
ROICexc growth 3Y-69.41%
ROICexc growth 5Y-37.84%
OM growth 3Y-63.89%
OM growth 5Y-37.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-32.21%
GM growth 5Y-16.29%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 4.61
Debt/EBITDA 4.29
Cap/Depr 89.54%
Cap/Sales 11.47%
Interest Coverage 0.38
Cash Conversion 176.29%
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 1.57
Altman-Z 2.6
F-Score5
WACC8.28%
ROIC/WACC0.04
Cap/Depr(3y)292.05%
Cap/Depr(5y)334.21%
Cap/Sales(3y)21.71%
Cap/Sales(5y)22.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.38%
EPS Next Y1051.57%
EPS Next 2Y263.09%
EPS Next 3Y149.67%
EPS Next 5Y94.11%
Revenue 1Y (TTM)-4.37%
Revenue growth 3Y-11.1%
Revenue growth 5Y10.45%
Sales Q2Q%15.94%
Revenue Next Year11.12%
Revenue Next 2Y8.63%
Revenue Next 3Y8.48%
Revenue Next 5Y11.41%
EBIT growth 1Y110.87%
EBIT growth 3Y-67.9%
EBIT growth 5Y-31.38%
EBIT Next Year2213.22%
EBIT Next 3Y201.65%
EBIT Next 5Y117.08%
FCF growth 1Y169.76%
FCF growth 3Y2.33%
FCF growth 5YN/A
OCF growth 1Y86.41%
OCF growth 3Y-12.4%
OCF growth 5Y9.93%

ALBEMARLE CORP / ALB Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ALBEMARLE CORP (ALB) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALB.


What is the valuation status of ALBEMARLE CORP (ALB) stock?

ChartMill assigns a valuation rating of 4 / 10 to ALBEMARLE CORP (ALB). This can be considered as Fairly Valued.


What is the profitability of ALB stock?

ALBEMARLE CORP (ALB) has a profitability rating of 1 / 10.


What is the financial health of ALBEMARLE CORP (ALB) stock?

The financial health rating of ALBEMARLE CORP (ALB) is 6 / 10.


What is the earnings growth outlook for ALBEMARLE CORP?

The Earnings per Share (EPS) of ALBEMARLE CORP (ALB) is expected to grow by 1051.57% in the next year.